DOI: 10.36347/sjmcr.2016.v04i09.010

Pages: 660-665

Lung cancer is a major public health problem. Just over one in eight lung cancer patients will be living 5 years after their diagnosis. Lung cancers are divided into two major groups-small cell and non-small cell. The non–small cell cancer category consists of adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and variants. Metastatic non-small-cell lung cancer is a common condition with a dismal prognosis. Although palliative chemotherapy improves survival and quality of life, nearly all patients die of progressive disease. Metastatic involvement of adrenal glands is not rare, but usually reflects widespread disease.